Antagonists of IGF: Vitronectin Interactions Inhibit IGF-I-Induced Breast Cancer Cell Functions

- Kashyap, Abhishek S., Shooter, Gary K., Hollier, Brett G., Shokoohmand, Ali, McGovern, Jacqui, Sivaramakrishnan, Manaswini, Croll, Tristan I., Cane, Gaëlle, Leavesley, David I., Söderberg, Ola, Upton, Zee

Inhibition of HSP90 by AUY922 preferentially kills mutant KRAS colon cancer cells by activating Bim through ER stress

- Wang, Chun Yan, Guo, Su Tang, Wang, Jia Yu, Liu, Fen, Zhang, Yuan Yuan, Yari, Hamed, Yan, Xu Guang, Jin, Lei, Zhang, Xu Dong, Jiang, Chen Chen

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma

- Carlino, Matteo S., Gowrishankar, Kavitha, Rizos, Helen, Saunders, Catherine A. B., Pupo, Gulietta M., Snoyman, Stephanie, Zhang, Xu Dong, Saw, Robyn, Becker, Therese M., Kefford, Richard F., Long, Georgina V.

Inhibition of dynamin by dynole 34-2 induces cell death following cytokinesis failure in cancer cells

- Chircop, Megan, Perera, Swetha, Sakoff, Jennette, O'Brien, Terence J., McCluskey, Adam, Robinson, Phillip J., Mariana, Anna, Lau, Hui, Ma, Maggie P. C., Gilbert, Jayne, Jones, Nigel C., Gordon, Christopher P., Young, Kelly A., Morokoff, Andrew

The dynamin inhibitors MiTMAB and OcTMAB induce cytokinesis failure and inhibit cell proliferation in human cancer cells

- Joshi, Sanket, Perera, Swetha, Chircop, Megan, Gilbert, Jayne, Smith, Charlotte M., Mariana, Anna, Gordon, Christopher P., Sakoff, Jennette A., McCluskey, Adam, Robinson, Phillip J., Braithwaite, Antony W.

Juxtamembrane mutant V560GKit is more sensitive to Imatinib (ST1571) compared with wild-type c-Kit whereas the kinase domain mutant D816VKit is resistant

- Frost, Michelle J., Ferrao, Petranel T., Hughes, Timothy P., Ashman, Leonie K.